Abbott Laboratories (ABT)
NYSE: ABT · IEX Real-Time Price · USD
105.24
-0.72 (-0.68%)
At close: Jul 26, 2024, 4:00 PM
99.00
-6.24 (-5.93%)
After-hours: Jul 26, 2024, 7:17 PM EDT
Abbott Laboratories Employees
Abbott Laboratories had 114,000 employees as of December 31, 2023. The number of employees decreased by 1,000 or -0.87% compared to the previous year.
Employees
114,000
Change (1Y)
-1,000
Growth (1Y)
-0.87%
Revenue / Employee
$353,737
Profits / Employee
$49,386
Market Cap
183.08B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 114,000 | -1,000 | -0.87% |
Dec 31, 2022 | 115,000 | 2,000 | 1.77% |
Dec 31, 2021 | 113,000 | 4,000 | 3.67% |
Dec 31, 2020 | 109,000 | 2,000 | 1.87% |
Dec 31, 2019 | 107,000 | 4,000 | 3.88% |
Dec 31, 2018 | 103,000 | 4,000 | 4.04% |
Dec 31, 2017 | 99,000 | 24,000 | 32.00% |
Dec 31, 2016 | 75,000 | 1,000 | 1.35% |
Dec 31, 2015 | 74,000 | -3,000 | -3.90% |
Dec 31, 2014 | 77,000 | 8,000 | 11.59% |
Dec 31, 2013 | 69,000 | -22,000 | -24.18% |
Dec 31, 2012 | 91,000 | 0 | - |
Dec 31, 2011 | 91,000 | 1,000 | 1.11% |
Dec 31, 2010 | 90,000 | 17,000 | 23.29% |
Dec 31, 2009 | 73,000 | 4,000 | 5.80% |
Dec 31, 2008 | 69,000 | 1,000 | 1.47% |
Dec 31, 2007 | 68,000 | 1,337 | 2.01% |
Dec 31, 2006 | 66,663 | 6,928 | 11.60% |
Dec 31, 2005 | 59,735 | -865 | -1.43% |
Dec 31, 2004 | 60,600 | -11,600 | -16.07% |
Dec 31, 2003 | 72,200 | 381 | 0.53% |
Dec 31, 2002 | 71,819 | 393 | 0.55% |
Dec 31, 2001 | 71,426 | 10,855 | 17.92% |
Dec 31, 2000 | 60,571 | 3,471 | 6.08% |
Dec 31, 1999 | 57,100 | 864 | 1.54% |
Dec 31, 1998 | 56,236 | 1,749 | 3.21% |
Dec 31, 1997 | 54,487 | 1,670 | 3.16% |
Dec 31, 1996 | 52,817 | 2,576 | 5.13% |
Dec 31, 1995 | 50,241 | 777 | 1.57% |
Dec 31, 1994 | 49,464 | -195 | -0.39% |
Dec 31, 1993 | 49,659 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Thermo Fisher | 122,000 |
AstraZeneca | 89,900 |
Pfizer | 88,000 |
Sanofi | 86,088 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Danaher | 63,000 |
Amgen | 26,700 |
ABT News
- 52 minutes ago - Abbott must pay $95 million in premature infant formula trial, jury finds - Reuters
- 10 hours ago - Should You Pick Abbott Stock At $105 After A Solid Q2? - Forbes
- 8 days ago - Abbott Laboratories Posts Big Drop in COVID-19 Testing Revenue - Investopedia
- 8 days ago - Nasdaq Down Over 100 Points; Abbott Laboratories Earnings Beat Views - Benzinga
- 8 days ago - Abbott plans marketing push for glucose monitors beyond diabetes - Reuters
- 8 days ago - Should you buy Abbott stock? CEO sees multi-billion dollar opportunity in new product - Invezz
- 8 days ago - Abbott raises annual profit forecast as strong medical device sales power quarterly beat - Reuters
- 8 days ago - Abbott Reports Second-Quarter 2024 Results and Raises Full-Year Guidance - PRNewsWire